Product Images Ambrisentan

This appears to be a table of drugs and their interactions. It includes drugs such as Cyclosporine, Mycophenolate Mofetl, Ketoconazole, Omeprazole, Rifampin, Ritonavir, Sildenafil, Tacrolimus, Tadalafil, and Warfarin. The table shows the recommended dose adjustments for each drug in the case of interacting with other drugs. However, there is not enough context to understand why these adjustments are necessary or what condition they are treating.*

This appears to be a chart or table showing various drugs and their recommendations for dose adjustment based on their interaction with other drugs. It includes information on Cmax, Auc, and K fold change with 90% CI recommendation. The drugs listed include Cyclosporine, Digoxin, Ethinylestradiol, Norethindrone, Mycophenolic acid, Ritonavir, Sildenafil, Desmethylsildenafil, Tadalafil, and R-Warfarin Ave. The chart also includes a timeline showing changes relative to the interacting drug alone. This could be useful for healthcare professionals managing patients on multiple medications.*

This seems to be a table showing the dosage of placebo and different amounts of a medication called "ARIES1" or "ARIES2" over a period of 12 weeks. It is unclear what the medication is for, or what the dosages represent (i.e. pills, mls, etc.).*

This appears to be a graph or chart that is measuring the "Event-Free %" over a certain period of time, possibly relating to the drug "Ambrisentan". The chart shows 3 at the start and then moves through weeks 0-12, with the different percentages marked on the Y-axis. There are three lines shown representing the different values for Ambrisentan, Placebo, and a third drug or metric denoted as "ARIES2". There is not enough information to determine the purpose of the chart or the context in which it was created.*

Each tablet of NOC 76282-684-30 contains 5mg of ambrisentan, a medicine used to treat high blood pressure in the lungs. It is recommended not to split, crush or chew the tablets. Patients should read the package insert for dosage and administration information. The tablets should be kept in the original container and the container should be tightly closed. The tablets are manufactured by Ipca Laboratories in India and distributed by Exelan Pharmaceuticals in the USA. Patients should receive a Medication Guide along with the tablets. Batch information such as serial number, expiry date and lot number will be overprinted during commercial packing.*

Ambrisentan is a medication available in the form of tablets, with each tablet containing 10mg of the drug. It is important not to crush, chew, or break the tablets. The medication should be stored at 25°C and the container should be tightly closed. Dispense the medication in its original container along with the medication guide attached to it. Dosage and administration should be carried out as directed in the package insert provided. The medication is manufactured by Cipla in Pataiganga, India, and is distributed through Exelan Pharmaceuticals Inc. based out of Boca Raton, FL. However, the description does not contain dosage and administration details.*